Celltrion’s Omlyclo is interchangeable with Xolair to treat the same conditions: asthma, chronic rhinosinusitis, food allergy ...

The hub has also been created to strengthen an existing relationship between Harvard and Roche that has been in place for over a decade.

TNKase — tenecteplase — is the first FDA-approved stroke medicine in nearly 30 years, offering a faster, simpler five-second ...

The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, f ...

Section 5A RTA 1988 - Driving or being in charge with concentration of specified controlled drug above specified limit The offence at section 5A RTA 1988 is driving, attempting to drive or being in ...

In 2020, Sue Bell became one of the first Alzheimer's patients in the U.S. to receive the drug now marketed as Leqembi. Four years later, she and her husband, Ken, halted the treatment.

The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will go into effect about two months later than planned, according to ...

On that note, time to hustle. Best of luck, and do keep in touch. … Eli Lilly will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells ...

Brian Pacheco New York The writer is the managing director of communications for the Drug Policy Alliance. To the Editor: Nicholas Kristof’s column starts with a faulty and harmful premise ...

The launch of the initiative, which is informed by survey results, comes one year after the drugmakers won FDA approval for Xolair in people with food allergies. One year ago, Roche—Genentech ...

to the Food and Drug Administration in November and it was accepted in January. The suit alleges that Amgen did not provide sufficient information about the manufacture of the product that would allow ...